IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v41y2018i1d10.1007_s40264-017-0591-5.html
   My bibliography  Save this article

Enrollment and Retention in 34 United States Pregnancy Registries Contrasted with the Manufacturer’s Capture of Spontaneous Reports for Exposed Pregnancies

Author

Listed:
  • Steven T. Bird

    (Center for Drug Evaluation and Research, Food and Drug Administration)

  • Kate Gelperin

    (Center for Drug Evaluation and Research, Food and Drug Administration)

  • Lockwood Taylor

    (Center for Drug Evaluation and Research, Food and Drug Administration)

  • Leyla Sahin

    (Center for Drug Evaluation and Research, Food and Drug Administration)

  • Hoda Hammad

    (Division of Biostatistics and Epidemiology)

  • Susan E. Andrade

    (University of Massachusetts Medical School)

  • Mohamed A. Mohamoud

    (Center for Drug Evaluation and Research, Food and Drug Administration)

  • Sengwee Toh

    (Harvard Medical School and Harvard Pilgrim Health Care Institute)

  • Christian Hampp

    (Center for Drug Evaluation and Research, Food and Drug Administration)

Abstract

Introduction Pregnancy registries and spontaneous reports are essential pharmacovigilance tools to evaluate drug safety during pregnancy. Objectives The aim of this study was to evaluate postmarket capture of exposed pregnancies. Methods Pregnancy registries for drugs and biologics were identified in a systematic review. Through a standardized questionnaire, manufacturers provided information on (1) pregnancy registry enrollment and retention, and (2) worldwide receipt of spontaneous reports for exposed pregnancies. A validated algorithm for live-birth pregnancies allowed calculation of exposure rates per 100,000 live births using claims data. Results Among 34 products with a pregnancy registry, median (interquartile range) registry enrollment was 36 pregnancies (5–258) and median spontaneous report capture was 450 pregnancies (89–1192). Products used in >20/100,000 live births had a median registry enrollment of 490 pregnancies and median capture of 1061 spontaneously reported exposed pregnancies. Lower median registry enrollment and spontaneous report capture was observed for products used in 0.5–20/100,000 live births (36 from registries, 541 spontaneous reports) and

Suggested Citation

  • Steven T. Bird & Kate Gelperin & Lockwood Taylor & Leyla Sahin & Hoda Hammad & Susan E. Andrade & Mohamed A. Mohamoud & Sengwee Toh & Christian Hampp, 2018. "Enrollment and Retention in 34 United States Pregnancy Registries Contrasted with the Manufacturer’s Capture of Spontaneous Reports for Exposed Pregnancies," Drug Safety, Springer, vol. 41(1), pages 87-94, January.
    • Handle: RePEc:spr:drugsa:v:41:y:2018:i:1:d:10.1007_s40264-017-0591-5
    DOI: 10.1007/s40264-017-0591-5
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-017-0591-5
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-017-0591-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Diego F. Wyszynski & Mondira Bhattacharya & Oscar Martínez-Pérez & Anthony R. Scialli & Melissa Tassinari & Naor Bar-Zeev & Cheryl Renz & Sonia Hernández-Díaz, 2023. "The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations," Drug Safety, Springer, vol. 46(3), pages 297-308, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:41:y:2018:i:1:d:10.1007_s40264-017-0591-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.